|
MLL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.355500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.108360E-01 |
| Normal-vs-Stage2 |
2.268800E-01 |
| Normal-vs-Stage3 |
3.574800E-01 |
| Normal-vs-Stage4 |
4.527800E-01 |
| Stage1-vs-Stage2 |
5.543400E-01 |
| Stage1-vs-Stage3 |
9.492800E-01 |
| Stage1-vs-Stage4 |
9.000800E-01 |
| Stage2-vs-Stage3 |
6.287000E-01 |
| Stage2-vs-Stage4 |
6.272600E-01 |
| Stage3-vs-Stage4 |
8.972800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.600600E-01 |
| Normal-vs-AfricanAmerican |
4.980300E-02 |
| Normal-vs-Asian |
4.278600E-01 |
| Caucasian-vs-AfricanAmerican |
2.515200E-01 |
| Caucasian-vs-Asian |
5.703800E-01 |
| AfricanAmerican-vs-Asian |
6.122000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.544200E-01 |
| Normal-vs-Female |
3.861400E-03 |
| Male-vs-Female |
1.537730E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.421000E-01 |
| Normal-vs-Extreme_Weight |
2.883000E-01 |
| Normal-vs-Obese |
4.414100E-02 |
| Normal-vs-Extreme_Obese |
5.114400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.719000E-01 |
| Normal_Weight-vs-Obese |
4.955200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.725800E-01 |
| Extreme_Weight-vs-Obese |
2.630400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.357600E-01 |
| Obese-vs-Extreme_Obese |
1.610760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.344900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.435500E-03 |
| Normal-vs-Age(61-80Yrs) |
9.997400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.514400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.377800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.901300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.839500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.755200E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.571430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.417200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.663300E-03 |
| Normal-VS-Type2 PRCC |
3.769700E-02 |
| Normal-VS-KIRP CIMP |
2.682900E-03 |
| Normal-VS-Unclassified PRCC |
1.151380E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.62229998721142E-09 |
| Type1 PRCC-VS-KIRP CIMP |
2.963400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.461400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.90729995633399E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
2.281200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.318600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.554000E-01 |
| Normal-vs-N1 |
6.466200E-02 |
| Normal-vs-N2 |
3.533000E-01 |
| N0-vs-N1 |
2.683800E-02 |
| N0-vs-N2 |
4.034400E-01 |
| N1-vs-N2 |
7.844800E-01 |
|
|
